For more information, ask your doctor or pharmacist. Please see the RITUXAN full Prescribing Information, including the Medication Guide, for additional. 13 Oct rituximab. PART I: HEALTH PROFESSIONAL INFORMATION. SUMMARY PRODUCT INFORMATION. Route of. Administration. Dosage Form /. Rituxan® SC. rituximab. Product Monograph. RITUXAN SC Product Monograph · Consumer Information. The files in this section are available in
|Published (Last):||8 November 2015|
|PDF File Size:||5.81 Mb|
|ePub File Size:||10.99 Mb|
|Price:||Free* [*Free Regsitration Required]|
Tell your healthcare provider right rituxan prescribing information informarion you have any of the following signs or symptoms of TLS: Call your doctor for medical advice about side effects.
Prescribihg infusions for serious or life-threatening cardiac arrhythmias. A commercial insurance plan such as one you get through your inofrmation or through a Health Insurance Marketplace like HealthCare.
Tell your healthcare provider or get medical help right away if you get any of these symptoms at any time during your treatment with Rituxan: Renal toxicity has occurred in patients who experience tumor lysis syndrome rituxan prescribing information in patients with administered concomitant cisplatin therapy rituxan prescribing information clinical trials.
RITUXAN® (rituximab) Rheumatoid Arthritis Treatment
In severe cases, increase in bilirubin levels, liver failure, and death can occur Screen all patients for HBV infection by measuring HBsAg and anti-HBc before initiating treatment with a rituximab-containing product. Talk to your healthcare provider about effective birth control. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
Before receiving Rituxan, patients should rituxan prescribing information their healthcare provider if they: Tell your healthcare provider right away if you have any stomach-area pain rituxan prescribing information treatment with Rituxan What are common side effects during treatment with Rituxan? Click “OK” if rituaxn are a healthcare professional.
Visit Genentech Access to Care Foundation for more information.
Your healthcare provider may monitor your heart during and after treatment with RITUXAN if you have symptoms of heart problems or have a history rituxan prescribing information heart problems. PML can result in death or rituxan prescribing information disability. In the experience with Rituxan in RA patients, the rate of serious infection was 4.
Tell your healthcare provider right away if you have any rituxa of infection: Rituxan administration can result in serious, including fatal infusion rituxan prescribing information. There is no known treatment, prevention, or cure for PML. There is no known treatment, prevention, or cure for PML Before receiving Rituxan, informaiton should tell their healthcare provider if they: The link you have selected will take rituxan prescribing information away from this site to one that is not owned or controlled by Genentech, Inc.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech USA, Inc.
Fatal serious rituxan prescribing information included pneumonia, rituxah, and colitis. Especially tell your healthcare provider if you take or have taken: Severe, including fatal, mucocutaneous reactions can rituxan prescribing information in patients receiving Rituxan. Other side effects include: Infusion-related reactions Infections may include fever, chills Body aches Tiredness Nausea.
Your healthcare provider should give you medicines before your infusion of RITUXAN to decrease your chance of having a severe infusion reaction. PML can result in death or serious disability. South San Francisco, CA: The information contained in this section of the site is intended for U.
Genentech does not recommend and does not endorse the content on any third-party websites.
Resources and support
It is available only for a patient or their guardian who is 18 years or older. RITUXAN can increase your risk of getting infections and can lower the ability of your immune system to fight infections. Females who are able to become pregnant should use effective birth control contraception during treatment with Rituxan and for 12 months after the last dose rituxan prescribing information Rituxan.
We may be able to help. Some of these people with low antibody levels developed infections. Tell your rituxan prescribing information provider right away if you have any rituxan prescribing information the following signs or symptoms of TLS: Genentech does not recommend and does not endorse the content on any third-party websites.
There is no known treatment, prevention, or cure for PML. People with weakened immune systems can get PML.
This syndrome may be associated with acute respiratory failure and death. Infusion reactions are very common side effects of Rituxan treatment. Rituxan prescribing information Side Effect Information. Rituxan can cause serious side effects that can lead to death, including: Tell your healthcare rituxan prescribing information or get medical help right away if you get any of these symptoms at any time during your treatment with RITUXAN: Advise pregnant women of the risk to a fetus Presribing are no data on the presence of rituximab or hyaluronidase human in human milk, the effect on the breastfed infant, or the effect on milk production.
People with weakened immune systems can get PML.
Females who are able to become pregnant should use effective birth control contraception during rituxan prescribing information with Rituxan and for 12 months after the last dose of Rituxan are breastfeeding or plan to breastfeed.
Prescribing Information Medication Guide. TLS is caused by the fast breakdown of cancer cells. This set of reactions which includes syndrome of cytokine release, tumor lysis syndrome, and anaphylactic and hypersensitivity reactions are rituxan prescribing information below.
The link you have selected will rituxan prescribing information you away from this presfribing to one that is not owned or controlled by Genentech, Inc. Serious infections can happen during and after treatment with Rituxan and can lead to death. Some of these patients with low antibody levels developed infections.
Infusion reactions, severe skin and mouth reactions, hepatitis B virus HBV reactivation and progressive multifocal leukoencephalopathy PML. Rituxan is not recommended for use in patients with severe, active infections.